Home Dialysis Central special follow-up on PD
[Vol.3, No.12, December 21, 2006]
For kidney professionals who don't subscribe to the Kidney International journal, we've compiled the links to all of the abstracts from the special supplement on PD (November, 2006). You can find them below.
Note to dialyzors: Kidney International is a medical journal for professionals. Feel free to read the abstracts—and please write and let us know if there is information you think we should focus on for a future "Topic of the Month" article. We love to hear from you!
Happy Holidays from the Home Dialysis Central team.
- Mortality studies comparing PD and HD: What do they tell us?
- French PD registry (RDPLF): Outline and main results
- PD in the US: Evaluation of outcomes in contemporary cohorts
- Selected best demonstrated practices in PD access
- Use of the embedded PD catheter: Experience and results from a North American Center
- Prevention of infectious complications in PD: Best demonstrated practices
- Microbiology and outcomes of peritonitis in North America
- Impact of new dialysis solutions on peritonitis rates
- Place of PD in the management of treatment-resistant congestive heart failure
- The role of PD in the management of treatment-resistant congestive heart failure: A European perspective
- Mitigating peritoneal membrane characteristics in modern PD therapy
- Profiles of automated PD prescriptions in the US 1997-2003
- Tidal PD: Its role in the current practice of PD
- The role of tidal PD in modern practice: A European perspective
- Glucose sparing in PD: Implications and metrics
- New insight of amino-acid based dialysis solutions
- Management of hyperlipidemia in patients on PD: Current approaches
- Structural requirements for a successful PD program
- Nosogogy: When the learner is a patient with chronic renal failure
- Patient retraining in PD: Why and when it is needed
- Patient and technique survival on peritoneal dialysis in patients with failed renal allograft: A case-control study
- Place of genotyping and phenotyping in understanding and potentially modifying outcomes in PD patients